Most importantly, the practice of benefit-cost analysis has been reinforced by decades of bipartisan presidential agreement, ...
Survival analysis of pyrotinib in HER2-positive metastatic breast cancer: A multicenter real-world study. A randomized, double-blind, three-arm, parallel group, phase 1 study to assess the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results